Search results
Moderna’s Covid-19 vaccine meets primary efficacy endpoint in Phase III trial
Clinical Trials Arena via Yahoo Finance· 32 minutes agoStéphane Bancel said: “We are very pleased that mRNA-1283 has now met its primary vaccine efficacy...
NHS genomics testing will be vital in supporting personalised cancer trials
Clinical Trials Arena via Yahoo Finance· 12 minutes agoPeter Johnson, national clinical director for cancer of NHS England said that the genomic medicine ...
COVID summer guide: How to navigate symptoms, variants and vaccines this season
Yahoo Life· 13 hours agoHowever, you'll no longer be able to order free tests from the U.S. government. The program was...
Joe Rogan calls out Trump—"He hasn't corrected course"
Newsweek· 2 days agoWhile president in 2020, Trump signed an executive order to help expedite access to vaccines in the...
Former GB News presenter says Ofcom killed his career over Covid vaccine claims
Daily Telegraph· 3 days agoThe presenter left GB News after the media regulator found two of his programmes, which featured...
Moderna's mRNA-1283 vaccine shows promise in Phase 3 trial By Investing.com
Investing.com· 19 hours agoModerna , Inc. (NASDAQ:MRNA) has announced successful results from the Phase 3 trial of its...
New RSV shots tied to rare nervous system disorder — should you worry?
LiveScience· 12 hours agoThe available vaccines include one called Arexvy and another called Abrysvo. The recent research —...
Vaccine critics misrepresent US appeals court ruling over Covid-19 shots
AFP via Yahoo News· 3 days agoVaccine skeptics are claiming a US federal appeals court ruled in June 2024 that Covid-19 shots are...
Gavi launches vaccine programs for Ebola, meningitis, rabies, and hepatitis B
Center for Infectious Disease Research and Policy· 4 hours agoGavi's expanded vaccine portfolio fits its goal of ensuring that lower-income countries have access to key vaccines as soon as possible.
Results are looking promising for a combined COVID and flu vaccine. Here’s how it could benefit...
The Conversation· 4 hours agoEarlier this week, Moderna announced positive results for its phase 3 clinical trial of a combined vaccine against COVID and influenza. Combination vaccines